Search bioRxiv⌕ Search

Biology subjects

Teles, F.

Publications and source records attributed to Teles, F..

2 recordsLinked to original sources

The Sequential Threshold Model: A Unified Framework for Microbiome-Driven Periodontitis Progression

Periodontitis affects nearly one billion people, yet its episodic, site-specific, age-dependent progression is not explained by linear pathogen-burden models. We propose the Sequential Threshold Model (STM), a bistable framework in which progression at a previously diseased but currently stable site requires two sequential events. First, a systemic host gate opens: butyrate-driven histone deacetylase (HDAC) inhibition and NF-{kappa}B blockade reduce the senescence-associated secretory phenotype (SASP) surveillance program below the level needed to contain a dysbiotic biofilm. Second, a local microbial gate is crossed when a critical hemin threshold initiates gingipain-dependent positive feedback. Two longitudinal paired-site cohorts, subgingival metatranscriptomic and gingival crevicular fluid, support a six-month transcriptomic breakpoint, a predicted cytokine hierarchy, and primarily cell-state divergence. Formalized as an age-dependent ordinary differential equation, the STM explains five clinical phenomena as consequences of bistability and yields six testable predictions, with implications for epigenetic biomarkers and host-targeted therapy.

microbiology↗

Synergic Renoprotective Effects Of Combined ASC Therapy With RAAS Blockade In Experimental Advanced CKD

Global prevalence of chronic kidney disease (CKD) has increased considerably in the recent decades. Overactivity of the renin-angiotensin-aldosterone system (RAAS), associated to renal inflammation and fibrosis contribute to its evolution. The treatments currently employed to control CKD progression are limited and mainly based on the pharmacological inhibition of RAAS, associated with diuretics and immunosuppressive drugs. However, this conservative management promotes only partial deceleration of CKD evolution, and does not completely avoid the progression of the disease and the loss of renal function, which motivates the medical and scientific community to investigate new therapeutic approaches to detain renal inflammation / fibrosis and CKD progression. Recent studies have shown the application of mesenchymal stem cells (mSC) to exert beneficial effects on the renal tissue of animals submitted to experimental models of CKD. In this context, the aim of the present study was to evaluate the effects of subcapsular application of adipose tissue-derived mSC (ASC) in rats submitted to the 5/6 renal ablation model, 15 days after the establishment of CKD, when the nephropathy was already severe. We also verify whether ASC associated to Losartan, would promote greater renoprotection when compared to the respective monotherapies. Animals were followed until 30 days of CKD, when body weight, systolic blood pressure, biochemical, histological, immunohistochemical and gene expression analysis were performed. The combination of ASC and Losartan was more effective than Losartan monotherapy in reducing systolic blood pressure and glomerulosclerosis, and also promoted the complete normalization of proteinuria and albuminuria, a significant reduction in renal interstitial macrophage infiltration and downregulation of renal IL-6 gene expression. The beneficial effects of ACS are possibly due to the immunomodulatory and anti-inflammatory role of factors secreted by these cells, modulating the local immune response. Although studies are still required, our results demonstrated that a subcapsular inoculation of ASC, associated with the administration of Losartan, exerted additional renoprotective effect in rats submitted to a severe model of established CKD, when compared to Losartan monotherapy, thus suggesting ASC may be a potential adjuvant to RAAS-blockade therapy currently employed in the conservative management of CKD.

physiology↗